Plain-English translation of NCT06570473 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether two medications— and —can help strengthen the right side of your heart and improve how well it works. You'll be randomly assigned to receive one of these medications plus your regular care, or to continue with your regular care alone. The study will follow you for 16 weeks to see how well the treatment works.
Right heart failure caused by high lung blood pressure is a serious condition, and doctors need better treatment options. This trial will help determine whether this medication could be an effective new tool to help your heart pump better.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to one of three groups: you'll either take once daily, twice daily (with a dose increase after 2 weeks), or continue with your standard care alone. Throughout the 16-week study, your doctors will monitor your progress by reviewing your medical records, tracking your symptoms, and checking blood work and heart imaging. You'll need a smartphone or tablet to help with study communication.
AI-generated summary from trial data · Jul 16, 2026 · Not medical advice
Canada